Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 2: We Don't Talk About Rylaze

Episode 2: We Don't Talk About Rylaze

FromWolverHeme Happy Hour


Episode 2: We Don't Talk About Rylaze

FromWolverHeme Happy Hour

ratings:
Length:
45 minutes
Released:
Mar 18, 2022
Format:
Podcast episode

Description

Bernie Marini and Anthony Perissinotti discuss asparaginase, the data (or lack thereof) behind the FDA approval of Rylaze (Erwinia asparaginase), and concerning trends regarding switches between asparaginase products in clinical practice! 
Released:
Mar 18, 2022
Format:
Podcast episode

Titles in the series (25)

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.